The identification of candidate effective combination regimens for pancreatic cancer using the histoculture drug response assay.

Scientific Reports
Eunsung JunSong Cheol Kim

Abstract

The prognosis for patients with pancreatic cancer is extremely poor, as they are resistant to first line chemotherapy. The long-term goal of this study was to identify effective combination chemotherapy for pancreatic cancer using pancreatic cancer surgical specimens in the histoculture drug response assay (HDRA) based on three-dimensional culture of tumour fragments, which maintains nature tumour histology in vitro. From 2015 to 2017, the HDRA was performed with tumour specimens from 52 pancreatic cancer patients from Asan Medical Hospital. First, combination drug regimens showed higher drug efficacy and less patient variation than single drugs. Initially, 5-Fluorouracil(5-FU)/Belotecan/Oxaliplatinum and Tegafur/Gimeracil (TS-1)/Oxaliplatinum/Irinotecan were found to be effective. Second, we were able to correlate the efficacy of some drugs with tumour stage. Third, when designing new combination regimens containing 5-FU or gemcitabine, we could identify more effective drug combinations. This is the first study to demonstrate usefulness of the HDRA for pancreatic cancer. Using this technique, we could identify novel candidate combination drug regimens that should be effective in treating pancreatic cancer.

References

Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R A VescioR M Hoffman
Dec 14, 2004·The Journal of Urology·Leland W K ChungHaiyen E Zhau
Jan 30, 2007·The Journal of Thoracic and Cardiovascular Surgery·Tatsuya YoshimasuTomoko Furukawa
Apr 5, 2007·Molecular Cancer Therapeutics·Daruka Mahadevan, Daniel D Von Hoff
Mar 13, 2009·General Thoracic and Cardiovascular Surgery·Tatsuya YoshimasuYoshitaka Okamura
Apr 30, 2010·The New England Journal of Medicine·Manuel Hidalgo
May 31, 2011·Lancet·Audrey VincentMichael Goggins
Feb 25, 2014·Journal of the National Cancer Institute·Davendra P S SohalAlok A Khorana
Nov 10, 2014·EMBO Reports·Michael W PickupValerie M Weaver
Nov 27, 2014·The New England Journal of Medicine·David P RyanNabeel Bardeesy
Nov 27, 2014·The New England Journal of Medicine·Matthew T Moyer, Ryan R Gaffney
Feb 20, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Clifford J WhatcottHaiyong Han
Apr 22, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lorraine A ChantrillUNKNOWN Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial Management Committee of the Australasian Gastrointestinal
Apr 29, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rodrigo DienstmannJosep Tabernero
May 9, 2015·Seminars in Cancer Biology·Abbas K SamadiXujuan Yang
Nov 4, 2015·Frontiers in Oncology·Vasiliki GkretsiTriantafyllos Stylianopoulos
Nov 23, 2015·Seminars in Cancer Biology·Keith I BlockMassimo Zollo
Feb 2, 2016·Cancer Letters·Stephen L ShiaoLeland W K Chung
Oct 30, 2016·Anticancer Research·Yoshiaki ShindenShoji Natsugoe
Nov 21, 2016·Lancet·Nadia Harbeck, Michael Gnant
Jul 19, 2017·Trends in Cancer·Leslie E OldfieldSteven Gallinger
Dec 20, 2017·Expert Review of Anticancer Therapy·Anteneh A TesfayePhilip A Philip
May 3, 2018·Nature Reviews. Gastroenterology & Hepatology·John P NeoptolemosDaniel H Palmer
Sep 23, 2018·Journal of Experimental & Clinical Cancer Research : CR·Serena VeschiAlessandro Cama
Dec 24, 2018·The New England Journal of Medicine·Thierry ConroyUNKNOWN Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group
May 31, 2019·Translational Gastroenterology and Hepatology·Ulla KlaiberJohn P Neoptolemos
Nov 15, 2019·HemaSphere·Deyan Y YosifovDaniel Mertens
Dec 11, 2019·Proceedings of the National Academy of Sciences of the United States of America·Else DriehuisHans Clevers

❮ Previous
Next ❯

Methods Mentioned

BETA
pancreatectomy
xenografts

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.